Gary L. Johnson, Ph.D.
Affiliations: | Pharmacology | University of Colorado, Boulder, Boulder, CO, United States |
Website:
http://www.med.unc.edu/pharm/people/primaryfaculty/gary-l-johnsonGoogle:
"Gary Johnson"Mean distance: 9.94
Parents
Sign in to add mentorJohn P. Perkins | grad student | 1976 | University of Colorado HSC |
Henry R. Bourne | post-doc | UCSF |
Children
Sign in to add traineeAaron C. Spalding | grad student | 2001 | University of Colorado, Denver |
Andrea H. Bild | grad student | 2002 | University of Colorado, Denver |
Katherine E. Lobel-Rice | grad student | 2002 | University of Colorado, Denver |
James A. Witowsky | grad student | 2002 | University of Colorado, Denver |
Lynn E. Heasley | post-doc | 1985-1991 | University Of Massachusetts Med Sch Worcester/National Jewish Research Ctr (Cell Biology Tree) |
Anne M. Gardner | post-doc | 1992-1996 | University of Colorado, Denver |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gomez SM, Drewry DH, Willson TM, et al. (2024) Illuminating function of the understudied druggable kinome. Drug Discovery Today. 103881 |
Joisa CU, Chen KA, Beville S, et al. (2023) Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies. Biorxiv : the Preprint Server For Biology |
Asquith CRM, Temme L, East MP, et al. (2022) Identification of 4-anilino-quin(az)oline as a cell active Protein Kinase Novel 3 (PKN3) inhibitor chemotype. Chemmedchem |
East MP, Johnson GL. (2021) Adaptive chromatin remodeling and transcriptional changes of the functional kinome in tumor cells in response to targeted kinase inhibition. The Journal of Biological Chemistry. 101525 |
Pucciarelli D, Angus SP, Huang B, et al. (2020) Nf1 mutant tumors undergo transcriptome and kinome re-modeling after inhibition of either mTOR or MEK. Molecular Cancer Therapeutics |
Goulet DR, Foster JP, Zawistowski JS, et al. (2020) Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer. Molecular Cancer Research : McR |
Garcia-Recio S, Thennavan A, East MP, et al. (2020) FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease. The Journal of Clinical Investigation |
Lipner MB, Peng XL, Jin C, et al. (2020) Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. Jci Insight |
Yesilkanal AE, Yang D, Tiwari P, et al. (2020) Abstract 5038: Limited inhibition of multiple nodes in a driver network blocks metastasis Cancer Research. 80: 5038-5038 |
Park SI, Lin CP, Ren N, et al. (2019) Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma. Targeted Oncology |